JBN Biotech ApS — Credit Rating and Financial Key Figures

JBN Biotech ApS (CVR number: 40685693) is a company from GENTOFTE. The company recorded a gross profit of -20.2 kDKK in 2023. The operating profit was -20.2 kDKK, while net earnings were -263.3 kDKK. The profitability of the company measured by Return on Assets (ROA) was 0.1 %, which can be considered weak but Return on Equity (ROE) was -0.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 74.9 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. JBN Biotech ApS's liquidity measured by quick ratio was 0 which is at a very low level. Thus, the company is in an unstable financial position, with its liquid assets significantly undermatching its current liabilities. This severe liquidity deficiency may lead to financial distress and threaten the company's operational continuity.